EFFECTIVE CONTROL, TREATMENT AND PREVENTION OF ANEMIA IN HEART FAILURE AND DISEASES IN THE FERGANA VALLEY
loading.default
item.page.date
item.page.authors
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Web of Journals Publishing
item.page.abstract
This study examines anemia correction protocols in 284 cardiovascular patients across three clinical centers in the Fergana Valley during 2022-2024. Combined iron supplementation with erythropoiesis-stimulating agents demonstrated hemoglobin elevation from 98.4 g/L to 118.7 g/L over 16 weeks, alongside reduced hospitalization rates by 34% and improved functional capacity in NYHA class II-III patients with concurrent heart failure and iron deficiency anemia.